Condition: Subarachnoid Hemorrhage, Spontaneous · Sponsor: UMC Utrecht
The purpose of this registry is to collect detailed information on the characteristics, treatment, and outcomes of patients with a subarachnoid hemorrhage. This information will enable research aimed at improving the safety and effectiveness of current and future treatments. By studying these data, the investigators aim to identify which treatment strategies offer the best results and which factors are most important in the care of patients with a subarachnoid hemorrhage. The knowledge gained from this research will help improve patient care in the future.
This description comes directly from the study's public registry record.
P.B. van Wijngaarden, MD · +88 755 5555 · measure@umcutrecht.nl
Always discuss trial participation with your own doctor first.
| Radboud University Medical Center | Nijmegen, Gelderland, Netherlands | Recruiting |
| Maastricht University Medical Center+ | Maastricht, Limburg, Netherlands | Recruiting |
| Elisabeth-Tweesteden Hospital | Tilburg, North Brabant, Netherlands | Recruiting |
| Amsterdam University Medical Center | Amsterdam, North Holland, Netherlands | Recruiting |
| Isala | Zwolle, Overijssel, Netherlands | Recruiting |
| University Medical Center Groningen | Groningen, Provincie Groningen, Netherlands | Recruiting |
| Erasmus University Medical Center | Rotterdam, South Holland, Netherlands | Recruiting |
| Haaglanden Medical Center | The Hague, South Holland, Netherlands | Recruiting |
| Utrecht University Medical Center | Utrecht, Utrecht, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07482124